Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC).

标题
Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC).
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 28, Issue 15_suppl, Pages 7531-7531
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2017-02-24
DOI
10.1200/jco.2010.28.15_suppl.7531

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started